Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2012
11/14/2012EP2522664A1 Piperidine derivatives as NK1 antagonists
11/14/2012EP2521723A1 Process for the preparation of rivaroxaban and intermediates thereof
11/14/2012EP2521722A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874
11/14/2012EP2521717A1 Method for the preparation of rivaroxaban
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012EP2521450A1 Fungicidal heterocyclic compounds
11/14/2012CN102781936A Heterocyclic compound having azole group
11/14/2012CN102781935A Extracts from kibdelos porangium as antibacterial agents
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781923A 5-alkynyl-pyrimidines
11/14/2012CN102781915A Inhibitors of diacylglycerol acyl transferase
11/14/2012CN102781910A Alkylamine derivative
11/14/2012CN102775367A Synthetic method of 3,4,5-tri-substituted oxazole-2-one
11/14/2012CN101891736B 1,3,4-thiadiazole (oxadiazole) derivatives based on benzoisoselenothiazolidone structure, and preparation method and application thereof
11/14/2012CN101874028B 2-aza-bicyclo[3.3.0]octane derivatives
11/14/2012CN101812055B Compound and method applying same for fluorescence detection of activity of monoamine oxidase
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/14/2012CN101535268B Tyrosine kinase inhibitors
11/14/2012CN101528726B Thiophene derivatives as S1P1/EDG1 receptor agonists
11/14/2012CN101400662B Substituted isoxazoline compound and pest control agent
11/14/2012CN101087609B Factor Xa compounds
11/13/2012US8309721 HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012US8309584 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists
11/13/2012US8309577 Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
11/13/2012US8309571 Heterobicyclic compounds useful as kinase inhibitors
11/13/2012US8309561 Phenylalanine derivatives
11/13/2012US8309555 Compositions and methods for inducing cell dedifferentiation
11/13/2012US8309549 Compositions for modulating a kinase cascade and methods of use thereof
11/13/2012US8309548 Benzene, pyridine, and pyridazine derivatives
11/13/2012US8309547 Processes for the preparation of rivaroxaban and intermediates thereof
11/13/2012US8309546 Morpholinopurine derivatives
11/13/2012US8309545 Benzofuran potassium channel blockers and uses thereof
11/13/2012US8309543 Compositions useful as inhibitors of voltage-gated sodium channels
11/13/2012CA2495777C Synergistic uv absorber combination
11/13/2012CA2454306C Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
11/08/2012WO2012151562A1 Combination pharmaceutical compositions and uses thereof
11/08/2012WO2012150183A1 Crystalline sodium salt of an hiv integrase inhibitor
11/08/2012WO2012118812A3 Substituted 6,5-fused bicyclic heteroaryl compounds
11/08/2012WO2012092409A3 Macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/08/2012US20120283439 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
11/08/2012US20120283434 Process for the preparation of rivaroxaban and intermediates thereof
11/08/2012US20120283433 Novel processes for the preparation of cyclopropyl-amide derivatives
11/08/2012US20120283297 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
11/08/2012US20120283295 Indazole derivatives and their use for blockading voltage dependent sodium channels
11/08/2012US20120283264 Oxazolidinones as Modulators of MGLUR5
11/08/2012US20120283261 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283259 Novel inhibitors
11/08/2012US20120283256 New heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
11/08/2012US20120283254 Novel benzofurane-piperidine compounds
11/08/2012US20120283242 Di - substituted pyridine derivatives as anticancers
11/08/2012US20120280613 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode
11/08/2012US20120280221 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same
11/08/2012CA2836769A1 Combination pharmaceutical compositions and uses thereof
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012EP2519511A1 Novel piperine derivatives as gaba - a receptors modulators
11/07/2012EP2519506A1 Hepatitis c virus inhibitors
11/07/2012EP2519504A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
11/07/2012EP2519503A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
11/07/2012EP2519500A1 Inhibitors of diacylglycerol acyl transferase
11/07/2012EP2519102A2 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/07/2012CN102770425A Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
11/07/2012CN102770419A Dihydrofuran derivatives as insecticidal compounds
11/07/2012CN102770415A Polycyclic compounds as lysophosphatidic acid receptor antagonists
11/07/2012CN102770182A Substituted isoquinolinones and quinazolinones
11/07/2012CN102766139A Azilsartan polymorphic substance and preparation method thereof
11/07/2012CN102766138A Preparation method of azilsartan
11/07/2012CN102766137A Method for preparing high-purity isradipine
11/07/2012CN102766095A Preparation method of electron-deficient group-containing multi-substituted pyrazole derivative
11/07/2012CN102153546B Bi-1,3,4-oxadiazole-containing compound and method for preparing material with extremely low laser threshold value by using compound
11/07/2012CN102040594B C2 axisymmetric chiral bisoxazoline ligand compound containing imidazole salt ion pair group, and preparation and application thereof
11/07/2012CN101948458B Baicalein derivatives with antitumor activity and application thereof in medicines
11/07/2012CN101786992B 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof
11/07/2012CN101497602B Anthranilic acid compound and use thereof
11/07/2012CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/06/2012US8304554 Compound, composition and thin film
11/06/2012US8304547 Azolecarboxamide compound or salt thereof
11/06/2012US8304539 Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
11/06/2012US8304538 Method of producing benzoxazinone-based compound
11/06/2012US8304423 Modulators of muscarinic receptors
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304412 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
11/06/2012US8304411 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/01/2012WO2012149528A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
11/01/2012WO2012149236A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
11/01/2012WO2012148622A1 Herbicidal pyrazinones
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147832A1 Phenyl pyrrole derivative crystal
11/01/2012WO2012147764A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity
11/01/2012WO2012147763A1 Oxazine derivative and bace 1 inhibitor containing same
11/01/2012WO2012146692A1 Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
11/01/2012WO2012146318A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
11/01/2012WO2012118715A3 Non-peptidic quenched fluorescent imaging probes
11/01/2012WO2012115446A3 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
11/01/2012WO2012104874A3 Aqueous concentrated formulation of linezolid
11/01/2012US20120277439 PYRIDINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC RING AND y-GLUTAMYLAMINO GROUP, AND ANTIFUNGAL AGENTS CONTAINING SAME
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 647